Headache Unit, Neurology Department, Hospital Universitari Vall d'Hebron, Barcelona, Spain.
Headache and Neurological Pain Research Group, Vall d'Hebron Research Institute, Department of Medicine, Universitat Autònoma de Barcelona, Barcelona, Spain.
Headache. 2020 May;60(5):916-928. doi: 10.1111/head.13774. Epub 2020 Feb 18.
To describe the 10-year evolution of a cohort of migraine patients, focusing on prognostic factors of improvement.
Migraine is one of the most prevalent and disabling diseases and migraineurs often want to know about the evolutionary timeline of their condition. Yet, data from longitudinal studies with a long-term follow-up is scarce.
This is a 10-year longitudinal study. In 2008, we recruited 1109 consecutive migraine patients who answered an initial survey. In 2018, we did a follow-up. We compared initial and final (after 10 years) data. A reduction ≥50% in Headache days/month was considered as improvement. A comparative study was carried out to identify predictors of improvement or no improvement.
After 10 years, 380 patients completed the survey (34.3% of the initial cohort), 77.1% (293/380) were women; mean age 41.0 ± 10.6 years and 73.7% (280/380) had an initial diagnosis of episodic migraine (EM). After 10 years, 48.2% (183/380) of patients did not have a medical follow-up of their migraine; 47.4% (180/380) decreased ≥50% in frequency, which increased the proportion of EM (73.7% vs 87.4%) (P < .001) as compared to the initial results. Factors independently associated with improvement were: a baseline frequency >10 days/month (OR[95%]: 3.04 [1.89, 4.89]; P < .001), nonsmoking (2.13 [1.23, 3.67]; P = .006) and a medical follow-up for migraine (2.45 [1.54, 3.90]; P < .001). Additionally, after 10 years, we observed a reduction in the use of preventive treatment (48.7% vs 23.5%) and an increase in monotherapy (42.2% vs 72.7%) (P < .001).
After 10 years, in almost half of the patients who answered the survey, migraine improved. Other than the natural pathophysiology of migraine, having a medical follow-up and healthy habits such as nonsmoking were independent factors associated with improvement.
描述偏头痛患者队列的 10 年演变,重点关注改善的预后因素。
偏头痛是最常见和最致残的疾病之一,偏头痛患者通常想了解他们病情的演变时间表。然而,长期随访的纵向研究数据很少。
这是一项 10 年的纵向研究。2008 年,我们招募了 1109 名连续的偏头痛患者,他们回答了最初的调查。2018 年,我们进行了随访。我们比较了初始和最终(10 年后)的数据。头痛天数/月减少≥50%被认为是改善。进行了一项比较研究,以确定改善或无改善的预测因素。
10 年后,380 名患者完成了调查(初始队列的 34.3%),77.1%(293/380)为女性;平均年龄 41.0±10.6 岁,73.7%(280/380)为初始诊断为发作性偏头痛(EM)。10 年后,380 名患者中有 48.2%(183/380)没有对偏头痛进行医疗随访;47.4%(180/380)的频率降低≥50%,这使得 EM 的比例增加(73.7%对 87.4%)(P<.001)与初始结果相比。与改善独立相关的因素包括:基线频率>10 天/月(OR[95%]:3.04[1.89, 4.89];P<.001)、不吸烟(2.13[1.23, 3.67];P=.006)和偏头痛的医疗随访(2.45[1.54, 3.90];P<.001)。此外,10 年后,我们观察到预防性治疗的使用减少(48.7%对 23.5%)和单药治疗增加(42.2%对 72.7%)(P<.001)。
10 年后,在回答调查的近一半患者中,偏头痛得到了改善。除了偏头痛的自然病理生理学外,进行医疗随访和不吸烟等健康习惯是与改善相关的独立因素。